Literature DB >> 24353094

Review of nutritional supplements for the treatment of bipolar depression.

Jeffrey J Rakofsky1, Boadie W Dunlop.   

Abstract

Many patients view psychotropics with skepticism and fear and view nutritional supplements as more consistent with their values and beliefs. The purpose of this review was to critically evaluate the evidence base for nutritional supplements in the treatment of bipolar depression (BD). A literature search for all randomized, controlled clinical trials using nutritional supplements in the treatment of BD was conducted via PubMed and Ovid MEDLINE computerized database. The studies were organized into essential nutrients/minerals, nonessential nutrients, and combinations of nutritional products. Among essential nutrients/minerals, omega-3-fatty acids (O3FAs) have the strongest evidence of efficacy for bipolar depression, although some studies failed to find positive effects from O3FAs. Weak evidence supports efficacy of vitamin C whereas no data support the usefulness of folic acid and choline. Among nonessential nutrients, cytidine is the least supported treatment. Studies of N-acetylcysteine have not resolved its efficacy in treating acute depressive episodes relative to placebo. However, one study demonstrates its potential to improve depressive symptoms over time and the other, though nonsignificant, suggests it has a prophylactic effect. Studies of inositol have been mostly negative, except for 1 study. Those that were negative were underpowered but demonstrated numerically positive effects for inositol. There is no evidence that citicholine is efficacious for uncomplicated BD depression, though it may have value for comorbid substance abuse among BD patients. Finally, combination O3FA-cytidine lacks evidence of efficacy. The findings of this review do not support the routine use of nutritional supplements in the treatment or prophylaxis of BD depression. Studies with more rigorous designs are required before definitive conclusions can be made. Despite the inadequacy of the existing data, clinicians should remain open to the value of nutritional supplements: after all, lithium is a mineral too.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  bipolar disorder; clinical trials; depression; pharmacotherapy; treatment

Mesh:

Substances:

Year:  2013        PMID: 24353094     DOI: 10.1002/da.22220

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  5 in total

1.  Efficacy of folic acid as an adjunct to lithium therapy on manic-like behaviors, oxidative stress and inflammatory parameters in an animal model of mania.

Authors:  Samira Menegas; Gustavo C Dal-Pont; José H Cararo; Roger B Varela; Jorge M Aguiar-Geraldo; Taise Possamai-Della; Monica L Andersen; João Quevedo; Samira S Valvassori
Journal:  Metab Brain Dis       Date:  2019-12-15       Impact factor: 3.584

Review 2.  Ascorbic Acid to Manage Psychiatric Disorders.

Authors:  Morgana Moretti; Daiane Bittencourt Fraga; Ana Lúcia S Rodrigues
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

3.  Common use of dietary supplements for bipolar disorder: a naturalistic, self-reported study.

Authors:  Michael Bauer; Tasha Glenn; Jörn Conell; Natalie Rasgon; Wendy Marsh; Kemal Sagduyu; Rodrigo Munoz; Ute Lewitzka; Rita Bauer; Maximilian Pilhatsch; Scott Monteith; Peter C Whybrow
Journal:  Int J Bipolar Disord       Date:  2015-06-02

4.  Serum folate levels in bipolar disorder: a systematic review and meta-analysis.

Authors:  Yung-Chi Hsieh; Li-Shiu Chou; Ching-Hua Lin; Hung-Chi Wu; Dian-Jeng Li; Ping-Tao Tseng
Journal:  BMC Psychiatry       Date:  2019-10-22       Impact factor: 3.630

Review 5.  Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress-Induced Damage in Patients with Bipolar Disorder.

Authors:  Sahithi Madireddy; Samskruthi Madireddy
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.